Cleared Traditional

K923788 - SPACE LABS MODEL 90560 (FDA 510(k) Clearance)

K923788 · Spacelabs, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1993
Decision
496d
Days
-
Risk

K923788 is an FDA 510(k) clearance for the SPACE LABS MODEL 90560.

Submitted by Spacelabs, Inc. (Redmond, US). The FDA issued a Cleared decision on December 6, 1993 after a review of 496 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Spacelabs, Inc. devices

Submission Details

510(k) Number K923788 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 28, 1992
Decision Date December 06, 1993
Days to Decision 496 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
371d slower than avg
Panel avg: 125d · This submission: 496d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code LOS
Device Class -